Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 12 member 5 (SLC12A5), also known as KCC2, is a neuron-specific potassium-chloride cotransporter responsible for establishing the chloride ion gradient in neurons. It maintains low intracellular chloride concentrations, critical for synaptic inhibition via GABAergic signaling and cellular protection against excitotoxicity. KCC2 also plays a role in neuroplasticity and is implicated in epilepsy, Rett syndrome, colorectal cancer, and hepatocellular carcinoma. In cancer it can promote tumor growth/metastasis via gene amplification/overexpression.
Not applicable; target of therapeutics but no approved drugs directly target it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 12 member 5 (KCC2).